KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Recruiting now · Phase 2/Phase 3
Conditions studied: Myasthenia Gravis, Generalized Myasthenia Gravis
In brief
A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Patients with Myasthenia Gravis
Key facts
- Study ID
- NCT06193889
- Run by
- Kyverna Therapeutics
- People needed
- 66
- Starts
- 2024-08-28
- Expected to finish
- 2028-09-01
- Last updated by the study team
- 2026-07-29
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Ronald Reagan UCLA Medical Center — Los Angeles, California, United States (enrolling)
- University of California, Irvine — Orange, California, United States (enrolling)
- Stanford University Medical Center — Palo Alto, California, United States (enrolling)
- University of Miami — Miami, Florida, United States (enrolling)
- Indiana University Health — Indianapolis, Indiana, United States (enrolling)
- University of Missouri — Columbia, Missouri, United States (enrolling)
- Oregon Health & Science University — Portland, Oregon, United States (enrolling)
- Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States (enrolling)
- Houston Methodist Hospital — Houston, Texas, United States (enrolling)
- Intermountain Medical Center — Murray, Utah, United States (enrolling)
- Westmead Institute for Medical Research — Westmead, Australia (enrolling)
- Hospital Israelita Albert Einstein — São Paulo, Brazil (enrolling)
- Charite- Universitätsklinikum Berlin — Berlin, Germany (enrolling)
- Universitätsklinikum der Ruhr-Universität Bochum — Bochum, Germany (enrolling)
- Universitätsklinikum Hamburg-Eppendorf — Hamburg, Germany (enrolling)
- Medizinische Hochscule Hannover — Hanover, Germany (enrolling)
- Friedrich-Schiller-Universität Jena — Jena, Germany (enrolling)
- Universitätsklinik Magdeburg — Magdeburg, Germany (enrolling)
- Technical University Munich, Klinikum Rechts der Isar — Munich, Germany (enrolling)
- King's Faisal Specialist Hospital and Research Center — Riyadh, Kindom of Saudi Arabia, Saudi Arabia (enrolling)
- Cambridge University Hospital, Addenbrooke's Hospital — Cambridge, United Kingdom (enrolling)
- King's College Hospital — London, United Kingdom (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.